FDA reverses course on Regenxbio’s childhood gene therapy after rejection - statnews.com

FDA reverses course on Regenxbio’s childhood gene therapy after rejection statnews.com Exclusive | FDA Gives Third Rare-Disease Drug Another Shot, Regenxbio Says WSJ FDA reconsiders rejected rare-disease gene therapy Baton Rouge Business Report US FDA reverses course on Regenxbio's rare-disease gene therapy, backs accelerated approval bid Reuters In another reversal for rare disease field, FDA to reconsider Regenxbio gene therapy Fierce Biotech